Riskpilot← Back to searchSign inGet full accessQmed Consulting Team ApS
APSActiveCVR 37688312Købmagergade 53, 1.Engineering activities and related technical consultancy · NACE 7112Est. 2016— employeesqmed-consulting.com
Revenue 2024
DKK 7M
+45% vs 2023
EBITDA margin
7.9%
+72% vs 2023
Equity ratio
43.8%
Financial strength
Net profit 2024
DKK 383K
+68% vs 2023
| Revenue | DKK 7M | +45% |
| EBITDA | DKK 554K | +72% |
| Net profit | DKK 383K | +68% |
| Total assets | DKK 2,9M | +18% |
| Equity | DKK 1,3M | +43% |
| Employees | — | — |
Legal name
Qmed Consulting Team ApS
CVR number
37688312
Legal form
Anpartsselskab
NACE code
7112 · Engineering activities and related technical consultancy
Founded
13. maj 2016
Share capital
DKK 50.000
Employees
—
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør alene eller af hele direktionen i forening.
Company purpose
Selskabets formål er levering af tjenesteydelser relaterede til udvikling af medicinsk udstyr, lægemidler, kosttilskud, vitaminer og fødevarer, herunder planlægning og styring af kliniske forskningsaktiviteter, der udføres af bioteknologiske og farmaceutiske virksomheder, og at udføre aktiviteter relaterede hertil.
Address
Købmagergade 53, 1.
Phone
+4556641010
Email
info@qmed-consulting.com
Website
qmed-consulting.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 485 | 2.272 | 1.596 | 2.347 | 1.372 | 1.754 | 2.907 | 4.859 | 7.024 |
| Staff expenses | -450 | -2.158 | -1.578 | -2.190 | -1.260 | -1.622 | -2.670 | -4.536 | -6.470 |
| EBITDA | 35 | 114 | 18 | 157 | 112 | 133 | 238 | 323 | 554 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | 35 | 114 | 18 | 157 | 112 | 133 | 238 | 323 | 554 |
| Net financials | 0 | -3 | -18 | -28 | 6 | -5 | -39 | -30 | -63 |
| Profit before tax | 35 | 110 | -0 | 129 | 117 | 127 | 199 | 293 | 492 |
| Tax | 8 | 24 | 1 | 28 | 26 | 30 | 40 | 64 | 108 |
| Net profit | 27 | 86 | -1 | 100 | 92 | 97 | 158 | 229 | 383 |
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Total assets | 145 | 552 | 360 | 1.042 | 1.415 | 1.921 | 1.564 | 2.459 | 2.902 |
| Equity | 127 | 213 | 212 | 312 | 404 | 501 | 660 | 888 | 1.272 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 18 | 339 | 148 | 730 | 1.011 | 1.420 | 904 | 1.571 | 1.631 |
| Total debt | 18 | 339 | 148 | 730 | 1.011 | 1.420 | 904 | 1.571 | 1.631 |
EBITDA margin
7.9%
This company
15.8%
Market median
-50% vs market
20162024
Equity ratio
43.8%
This company
38.2%
Market median
+15% vs market
20162024
Return on equity
30.2%
This company
18.4%
Market median
+64% vs market
20162024
Net profit margin
5.5%
This company
8.1%
Market median
-32% vs market
20162024
Asset turnover
2.42×
This company
1.12×
Market median
+116% vs market
20162024
Debt / equity
1.28×
This company
0.62×
Market median
-106% vs market
20162024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-05-13 – 2016-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
MB Chief Executive Officer | Chief Executive Officer | 2019 | — | — |
HH Chief Executive Officer | Chief Executive Officer | 2023 | — | — |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
QMED CONSULTING A/S | Company | 100.0% | 100.0% | 2016 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
HMHANSEN HOLDING ApS
Qmed Consulting Team ApS Board members of Qmed Consulting Team ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Mikael Berendt-Møller | Chief Executive Officer | 0 companies |
| Helene Hansen | Chief Executive Officer | 0 companies |